港股异动 | 合一投资(0913.HK)飙升逾129% 暂列港股市场涨幅第一
格隆汇2月19日丨合一投资(0913.HK)飙升逾129%,暂列港股市场涨幅第一,报0.33港元,高见0.355港元创逾一年来新高,成交434万港元。合一投资昨日发布公告,于2021年2月18日,公司与配售代理订立配售协议,公司拟配售最多4469万股,相当于已发行股本20.00%,及经发行扩大后已发行股本约16.67%。每股配售股份0.130港元,较2月18日收市价每股0.144港元折让约9.7%。配售事项的所得款项净额约570万港元。公司拟将该等所得款项净额用于集团的一般营运资金以及根据公司的投资目标用作未来投资。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.